Humana (HUM) Tops Q1 EPS by 72c, Maintains FY EPS Guidance
Get Alerts HUM Hot Sheet
Price: $324.83 +0.42%
Revenue Growth %: +6.6%
Financial Fact:
Diluted earnings per common share: 2.98
Today's EPS Names:
MAXN, CSTR, ACU, More
Revenue Growth %: +6.6%
Financial Fact:
Diluted earnings per common share: 2.98
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Humana (NYSE: HUM) reported Q1 EPS of $5.40, $0.72 better than the analyst estimate of $4.68. Revenue for the quarter came in at $18.94 billion versus the consensus estimate of $18.46 billion.
GUIDANCE:
Humana sees FY2020 EPS of $18.25-$18.75, versus the consensus of $18.44.
- Humana is revising its GAAP EPS guidance range for the year ending December 31, 2020 (FY 2020) to $16.04 to $16.54 from the previous range of $17.76 to $18.26, reflecting the 1Q20 impact of the company's non-consolidating minority interest put/call valuation adjustments. While acknowledging the inherent uncertainty surrounding the ongoing crisis, Humana is maintaining its FY 2020 Adjusted EPS range of $18.25 to $18.75. For comparison, FY 2020 GAAP and Adjusted EPS guidance is detailed below along with GAAP and Adjusted results for the year ended December 31, 2019 (FY 2019).
- The company is revising its net membership growth estimate for its individual Medicare Advantage products now expecting growth in a range of 300,000 to 350,000 members for FY 2020 compared to the previous guidance growth range of 270,000 to 330,000 members. This anticipated increase in 2020 represents year-over-year growth of approximately 9 percent at the midpoint of the guidance range.
- The company is also reiterating its expectations for group Medicare Advantage net membership gains for FY 2020, projecting an increase of approximately 90,000 members year over year.
- For its stand-alone PDP business, Humana continues to estimate a net membership decline of approximately 550,000 members for FY 2020.
- Given the likelihood of significant variability of results by financial statement line item (and related ratios), Humana is withdrawing its additional detailed guidance that was initially provided as part of the company's fourth quarter 2019 earnings release dated February 5, 2020.
For earnings history and earnings-related data on Humana (HUM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix Q1 earnings top estimates on blowout subscriber growth
- Genuine Parts (GPC) Tops Q1 EPS by 5c, Offers Guidance
- Intuitive Surgiical (ISRG) beats earnings, revenue expectations in Q1
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!